Showing results (581-590 of 673) with videos related to

Sort By:
Pageof 68
Antimicrobial Agents and Chemotherapy|September 20, 2023
Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitisCharles D Giamberardino, Jennifer L Tenor, Dena L Toffaletti, et al.
The New England Journal of Medicine|January 26, 2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropeniaOliver A Cornely, Johan Maertens, Drew J Winston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2016
Isavuconazole Treatment of Cryptococcosis and Dimorphic MycosesGeorge R Thompson, Adrian Rendon, Rodrigo Ribeiro Dos Santos, et al.
Mbio|April 15, 2024
A ketogenic diet enhances fluconazole efficacy in murine models of systemic fungal infectionJulia R Palmucci, Blake E Sells, Charles D Giamberardino, et al.
Mycoses|April 4, 2018
Isavuconazole for treatment of rare invasive fungal diseasesOliver A Cornely, Kathleen M Mullane, Luis Ostrosky-Zeichner, et al.
Mycoses|April 4, 2018
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal speciesFrancisco M Marty, Oliver A Cornely, Kathleen M Mullane, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2014
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropeniaRafael F Duarte, Javier López-Jiménez, Oliver A Cornely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2023
Description of Cryptococcosis Following SARS-CoV-2 Infection: A Disease Survey Through the Mycosis Study Group Education and Research Consortium (MSG-19)Jeremey Walker, Todd McCarty, Gerald McGwin, et al.
Msphere|November 22, 2019
Regulatory Mechanism of the Atypical AP-1-Like Transcription Factor Yap1 in Cryptococcus neoformansYee-Seul So, Shinae Maeng, Dong-Hoon Yang, et al.
Pageof 68